Pharmobedient Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PHARMOBEDIENT, and what generic and branded alternatives to PHARMOBEDIENT drugs are available?
PHARMOBEDIENT has nineteen approved drugs.
Drugs and US Patents for Pharmobedient
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmobedient Cnsltg | LEVETIRACETAM | levetiracetam | SOLUTION;ORAL | 090028-001 | Mar 3, 2010 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pharmobedient Cnsltg | METOCLOPRAMIDE HYDROCHLORIDE | metoclopramide hydrochloride | SOLUTION;ORAL | 074703-001 | Oct 31, 1997 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Pharmobedient Cnsltg | DEXAMETHASONE | dexamethasone | ELIXIR;ORAL | 088254-001 | Jul 27, 1983 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.